Basilea Pharmaceutica AG
BPMUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $572,152 | $579,771 | $543,464 | $413,711 |
| - Cash | $128,365 | $120,700 | $62,963 | $59,900 |
| + Debt | $96,786 | $111,671 | $112,447 | $128,606 |
| Enterprise Value | $540,573 | $570,742 | $592,948 | $482,417 |
| Revenue | $103,960 | $132,250 | $76,293 | $72,729 |
| % Growth | -21.4% | 73.3% | 4.9% | – |
| Gross Profit | $41,436 | $145,285 | $24,577 | $55,931 |
| % Margin | 39.9% | 109.9% | 32.2% | 76.9% |
| EBITDA | $25,099 | $56,182 | $10,155 | $3,146 |
| % Margin | 24.1% | 42.5% | 13.3% | 4.3% |
| Net Income | $15,802 | $56,856 | $20,737 | -$21,389 |
| % Margin | 15.2% | 43% | 27.2% | -29.4% |
| EPS Diluted | 1.26 | 4.2 | 1.5 | -1.78 |
| % Growth | -70% | 180% | 184.3% | – |
| Operating Cash Flow | $23,056 | $56,443 | $17,920 | -$7,619 |
| Capital Expenditures | -$321 | -$1,325 | -$467 | -$645 |
| Free Cash Flow | $22,735 | $55,118 | $17,453 | -$8,264 |